
Sign up to save your podcasts
Or


Listen in as Zev A. Wainberg, MD; Paul E. Oberstein, MD; and Mark O’Hara, MD, discuss the evolving treatment landscape for metastatic pancreatic cancer, including:
Presenters
Paul E. Oberstein, MD
Associate Professor of Medicine
Section Chief, GI Oncology
Perlmutter Cancer Center
NYU Langone Health
New York, New York
Mark O’Hara, MD
Associate Professor of Medicine
Division of Hematology and Oncology
University of Pennsylvania
Philadelphia, Pennsylvania
Zev A. Wainberg, MD
Professor of Medicine and Surgery
Co-Director of GI Oncology
Director, Early Phase Clinical Research Program
Jonsson Comprehensive Cancer Center
UCLA School of Medicine
Los Angeles, California
Link to full program:
https://bit.ly/45NdBTx
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
By Clinical Care Options4.9
1010 ratings
Listen in as Zev A. Wainberg, MD; Paul E. Oberstein, MD; and Mark O’Hara, MD, discuss the evolving treatment landscape for metastatic pancreatic cancer, including:
Presenters
Paul E. Oberstein, MD
Associate Professor of Medicine
Section Chief, GI Oncology
Perlmutter Cancer Center
NYU Langone Health
New York, New York
Mark O’Hara, MD
Associate Professor of Medicine
Division of Hematology and Oncology
University of Pennsylvania
Philadelphia, Pennsylvania
Zev A. Wainberg, MD
Professor of Medicine and Surgery
Co-Director of GI Oncology
Director, Early Phase Clinical Research Program
Jonsson Comprehensive Cancer Center
UCLA School of Medicine
Los Angeles, California
Link to full program:
https://bit.ly/45NdBTx
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

321 Listeners

39 Listeners

67 Listeners

118 Listeners

11 Listeners

59 Listeners

258 Listeners

198 Listeners

187 Listeners

22 Listeners

53 Listeners

812 Listeners

58 Listeners

190 Listeners

41 Listeners